Study of Dynavax's 1018 ISS, Following Rituxan in Patients With B-Cell Follicular Lymphoma

This study has been completed.

Study NCT00251394 Information provided by Dana-Farber Cancer Institute

First Received: November 8, 2005 Last Updated: January 28, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	July 2009
Primary Completion Date:	December 2006 (Final data collection date for primary outcome measure)